PharmaResearch acquires TuringBio for digital therapeutics

PharmaResearch Co., a South Korean company specializing in regenerative medicine, announced on Wednesday that it acquired TuringBio, an AI-based digital healthcare solution firm. 

PharmaResearch aims to secure talent in digital therapeutics (DTx) and integrate AI technology into its aesthetic and medical businesses, enhancing its expertise and capabilities.

Founded in 2020, TuringBio is an AI-based digital healthcare solution company currently developing evidence-based depression digital therapeutics DepRx, a personalized comprehensive psychological counseling platform WeeDool utilizing generative AI, and VitalTracker, which tracks and predicts digital phenotype data necessary for the quantitative diagnosis of mental disorders.

These services are provided to hospitals and clinics.

Write to Ye-Jin Jun at ace@hankyung.com